Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association
- PMID: 1279219
- DOI: 10.1016/s0022-5347(17)36967-7
Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association
Abstract
We correlated the American Urological Association (AUA) symptom index with other indexes that have been used to measure symptoms for benign prostatic hyperplasia (BPH) and compared their psychometric properties. A self-administered questionnaire that allowed derivation of AUA, Maine Medical Assessment Program, Madsen-Iversen and Boyarsky symptom scores was completed by 76 men with clinically defined BPH, 59 younger control subjects, and 27 men before and after prostatectomy. The scores from the 4 indexes were strongly correlated (r = 0.77 to 0.93). All 4 indexes had good internal consistency and test-retest reliabilities. All indexes were predictive of patient global ratings of the degree of bother from the urinary condition. The AUA index discriminated BPH patients from controls significantly better than the Maine Medical Assessment Program index, and equivalently to the Madsen-Iversen and Boyarsky indexes (despite having fewer items). All 4 indexes were responsive when BPH patients underwent prostatectomy, although the AUA and Madsen-Iversen indexes were significantly more sensitive.
Comment in
-
25 Years of Experience with the AUA Symptom Index: Increasing Recognition that the Bladder is an Unreliable Witness.J Urol. 2017 Feb;197(2S):S198-S199. doi: 10.1016/j.juro.2016.10.082. Epub 2016 Dec 20. J Urol. 2017. PMID: 28010967 No abstract available.
Similar articles
-
Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group.Br J Urol. 1998 Jan;81(1):36-41. doi: 10.1046/j.1464-410x.1998.00524.x. Br J Urol. 1998. PMID: 9467474 Clinical Trial.
-
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.J Urol. 1992 Nov;148(5):1549-57; discussion 1564. doi: 10.1016/s0022-5347(17)36966-5. J Urol. 1992. PMID: 1279218
-
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia.J Urol. 2017 Feb;197(2S):S189-S197. doi: 10.1016/j.juro.2016.10.071. Epub 2016 Dec 22. J Urol. 2017. PMID: 28012747
-
Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores.Urol Clin North Am. 1995 May;22(2):299-307. Urol Clin North Am. 1995. PMID: 7539176 Review.
-
Symptom indices in bladder outlet obstruction.Br J Urol. 1996 Apr;77(4):494-501. doi: 10.1046/j.1464-410x.1996.09482.x. Br J Urol. 1996. PMID: 8777606 Review.
Cited by
-
Association of Sleep Disordered Breathing with Erectile Dysfunction in Community Dwelling Older Men.J Urol. 2017 Mar;197(3 Pt 1):776-782. doi: 10.1016/j.juro.2016.09.089. Epub 2016 Sep 30. J Urol. 2017. PMID: 27697577 Free PMC article.
-
Use of meta-analytic results to facilitate shared decision making.J Am Med Inform Assoc. 1999 Sep-Oct;6(5):412-9. doi: 10.1136/jamia.1999.0060412. J Am Med Inform Assoc. 1999. PMID: 10495100 Free PMC article.
-
Symptom scores: mumbo jumbo or meaningful measures?Curr Urol Rep. 2005 Jul;6(4):251-6. doi: 10.1007/s11934-005-0017-2. Curr Urol Rep. 2005. PMID: 15978223 Review.
-
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.Urology. 2009 May;73(5):950-7. doi: 10.1016/j.urology.2008.12.012. Urology. 2009. PMID: 19394490 Free PMC article.
-
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.Lancet. 2022 May 14;399(10338):1886-1901. doi: 10.1016/S0140-6736(21)01790-6. Lancet. 2022. PMID: 35569466 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical